News Quantified

VSTM – verastem, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Verastem (NASDAQ:VSTM) was given a new $18.00 price target on by analysts at Mizuho.

Verastem Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

Verastem (NASDAQ:VSTM) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $18.00 price target on the stock.

Verastem Oncology Provides Preliminary Fourth Quarter and 2025 Revenue and Business Updates and Outlines 2026 Strategic Priorities for Novel Portfolio Targeting RAS/MAPK Pathway-Driven Cancers

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

-14.6%

MISS

19.9%

MISS

-3.4%

MISS

Form SCHEDULE 13G Verastem, Inc. Filed by: ARMISTICE CAPITAL, LLC

Form SCHEDULE 13G/A Verastem, Inc. Filed by: Point72 Asset Management, L.P.

Form SCHEDULE 13G/A Verastem, Inc. Filed by: RTW INVESTMENTS, LP

Form SCHEDULE 13G/A Verastem, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.

Form SCHEDULE 13G/A Verastem, Inc. Filed by: Nantahala Capital Management, LLC

Top News Gainers

2/28 Verastem Oncology Announces New Strategic Direction to Advance Its Clinical Development Programs 59.4%

1/8 Verastem Oncology Announces Global Licensing Agreement with Chugai Pharmaceutical Co., Ltd. to Develop and Commercialize RAF/MEK Inhibitor CH5126766 43.3%

6/17 Verastem Oncology Presents COPIKTRA™ (Duvelisib) Data at the European Hematology Association 2019 Annual Meeting 24.1%

10/23 Verastem Oncology Announces COPIKTRA™ (Duvelisib) Presentations at the Lymphoma & Myeloma 2019 International Congress 21.6%

4/20 Verastem Oncology Announces Investor Conference Call to Discuss Clinical Data from Investigator-initiated RAF/MEK and FAK Combination Study in KRAS Mutant Solid Tumors 21.3%

2/3 Form SC 13G Verastem, Inc. Filed by: Point72 Asset Management, L.P. 14.2%

4/21 Form DEFA14A Verastem, Inc. 13.2%

3/5 Form 3 Verastem, Inc. For: Mar 03 Filed by: Kolchinsky Peter 12.3%

7/10 Form SC 13G/A Verastem, Inc. Filed by: BlackRock Inc. 10.7%

5/10 Verastem Inc (NASDAQ: VSTM) had its price target lowered by analysts at BTIG Research to $8.00. They now have a "buy" rating on the stock. 9.5%

Top News Decliners

4/27 Verastem Oncology Announces Preliminary Data from Investigator-initiated Study Highlighting Clinical Activity of RAF/MEK and FAK Combination in KRAS Mutant Tumors Presented at the American Association for Cancer Research 2020 Virtual Annual Meeting I -51.4%

5/9 Q1/2019 3/31/2019 EPS -0.520 ZacksConsensus -0.460 ActVsEst (0.060) - Miss -28.8%

3/11 Form 10-K Verastem, Inc. For: Dec 31 -26.1%

6/20 Verastem Oncology Announces Leadership Changes -17.2%

3/16 Verastem Inc (NASDAQ: VSTM) had its price target raised by analysts at HC Wainwright from $2.50 to $2.75. They now have a "buy" rating on the stock. -16.8%

8/1 Form 8-K Verastem, Inc. For: Jul 29 -16.7%

3/6 Form SC 13G/A Verastem, Inc. Filed by: Ridgeback Capital Investments L.P. -16.0%

10/29 Q3/2019 9/30/2019 EPS -0.350 ZacksConsensus -0.420 ActVsEst 0.070 - Beat -14.3%

4/28 Verastem Inc (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $2.75 price target on the stock. -14.2%

4/23 Form 8-K Verastem, Inc. For: Apr 23 -10.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day